AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 16, Issue 1, Pages 77-87
Publisher
Informa UK Limited
Online
2014-12-03
DOI
10.4161/15384047.2014.987021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting apoptosis for anticancer therapy
- (2015) Simone Fulda SEMINARS IN CANCER BIOLOGY
- Survivin beyond physiology: Orchestration of multistep carcinogenesis and therapeutic potentials
- (2014) Kalliopi Ch. Athanasoula et al. CANCER LETTERS
- Differential effects of AMPK agonists on cell growth and metabolism
- (2014) E E Vincent et al. ONCOGENE
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
- (2014) Y Feng et al. Cell Death & Disease
- Metformin is associated with improved survival in endometrial cancer
- (2013) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
- (2012) K. Kato et al. MOLECULAR CANCER THERAPEUTICS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
- (2011) R. A. Carrasco et al. MOLECULAR CANCER THERAPEUTICS
- Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
- (2010) Kristy A. Brown et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
- (2009) A. Vazquez-Martin et al. ANNALS OF ONCOLOGY
- Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now